Trials / Completed
CompletedNCT00375570
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
An Open Label, Multi-Centre, Phase III, Subject Initiated Safety Study of ME-609 in Treatment of Recurrent Herpes Simplex Labialis in Adolescents
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 254 (actual)
- Sponsor
- Medivir · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents.
Detailed description
The objective of the study was to evaluate the safety of ME-609 for the treatment of herpes labialis recurrences in immunocompetent adolescents, 12 - 17 years of age, following a 5-day treatment with 5-time daily topical administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ME-609 | Topical treatment 5 times daily for 5 days |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2006-09-13
- Last updated
- 2008-08-18
Source: ClinicalTrials.gov record NCT00375570. Inclusion in this directory is not an endorsement.